Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 163

The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.

Creatine metabolism and psychiatric disorders: Does creatine supplementation have therapeutic value?

Allen, Patricia J.·2012·Neuroscience & Biobehavioral Reviews
DOI 10.1016/j.neubiorev.2012.03.005
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.neubiorev.2012.03.005

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 238

  1. Agostinho, 2009, Effects of olanzapine, fluoxetine and olanzapine/fluoxetine on creatine kinase activity in rat brain, Brain Res. Bull., 80, 337, 10.1016/j.brainresbull.2009.09.002 · DOI
  2. Agren, 1988, Creatinine and creatine in CSF: indices of brain energy metabolism in depression. Short note, J. Neural Transm., 74, 55, 10.1007/BF01243575 · DOI · Paper page
  3. Allen, 2010, Chronic creatine supplementation alters depression-like behavior in rodents in a sex-dependent manner, Neuropsychopharmacology, 35, 534, 10.1038/npp.2009.160 · DOI · Paper page
  4. Allen, P.J., D’Anci, K.E., Kanarek, R.B., Renshaw, P.F., 2012 Sex-specific antidepressant effects of dietary creatine with and without sub-acute fluoxetine in rats. Pharmacol. Biochem. Behav., doi:10.1016/j.pbb.2012.03.005 (Epub ahead of print). · DOI
  5. Almeida, 2006, Exocytotic release of creatine in rat brain, Synapse, 60, 118, 10.1002/syn.20280 · DOI
  6. Almeida, 2008, Homocysteine and depression in later life, Arch. Gen. Psychiatry, 65, 1286, 10.1001/archpsyc.65.11.1286 · DOI
  7. Ames, 2000, CNS energy metabolism as related to function, Brain Res. Brain Res. Rev., 34, 42, 10.1016/S0165-0173(00)00038-2 · DOI · Paper page
  8. Amital, 2006, Open study of creatine monohydrate in treatment-resistant posttraumatic stress disorder, J. Clin. Psychiatry, 67, 836, 10.4088/JCP.v67n0521c · DOI
  9. Amital, 2006, Observed effects of creatine monohydrate in a patient with depression and fibromyalgia, Am. J. Psychiatry, 163, 1840, 10.1176/ajp.2006.163.10.1840b · DOI
  10. Andres, 2008, Functions and effects of creatine in the central nervous system, Brain Res. Bull., 76, 329, 10.1016/j.brainresbull.2008.02.035 · DOI · Paper page
  11. Andres, 2005, Effects of creatine treatment on the survival of dopaminergic neurons in cultured fetal ventral mesencephalic tissue, Neuroscience, 133, 701, 10.1016/j.neuroscience.2005.03.004 · DOI
  12. Assis, 2009, Effect of acute administration of ketamine and imipramine on creatine kinase activity in the brain of rats, Rev. Bras. Psiquiatr., 31, 247, 10.1590/S1516-44462009000300010 · DOI
  13. Assis, 2007, Effect of antipsychotics on creatine kinase activity in rat brain, Basic Clin. Pharmacol. Toxicol., 101, 315, 10.1111/j.1742-7835.2007.00128.x · DOI
  14. Astorino, 2005, Is running performance enhanced with creatine serum ingestion?, J. Strength Cond. Res., 19, 730
  15. Auer, 2000, Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study, Biol. Psychiatry, 47, 305, 10.1016/S0006-3223(99)00159-6 · DOI · Paper page
  16. Auer, 2001, Reduced NAA in the thalamus and altered membrane and glial metabolism in schizophrenic patients detected by 1H-MRS and tissue segmentation, Schizophr. Res., 52, 87, 10.1016/S0920-9964(01)00155-4 · DOI
  17. Battini, 2002, Creatine depletion in a new case with AGAT deficiency: clinical and genetic study in a large pedigree, Mol. Genet. Metab., 77, 326, 10.1016/S1096-7192(02)00175-0 · DOI
  18. Béard, 2010, Synthesis and transport of creatine in the CNS: importance for cerebral functions, J. Neurochem., 115, 297, 10.1111/j.1471-4159.2010.06935.x · DOI · Paper page
  19. Bebbington, 2003, The influence of age and sex on the prevalence of depressive conditions: report from the National Survey of Psychiatric Morbidity, Int. Rev. Psychiatry, 15, 74, 10.1080/0954026021000045976 · DOI · Paper page
  20. Bender, 2008, Creatine improves health and survival of mice, Neurobiol. Aging, 29, 1404, 10.1016/j.neurobiolaging.2007.03.001 · DOI · Paper page
  21. Benzi, 2000, Is there a rationale for the use of creatine either as nutritional supplementation or drug administration in humans participating in a sport?, Pharmacol. Res., 41, 255, 10.1006/phrs.1999.0618 · DOI
  22. Bertolino, 1998, Regionally specific neuronal pathology in untreated patients with schizophrenia: a proton magnetic resonance spectroscopic imaging study, Biol. Psychiatry, 43, 641, 10.1016/S0006-3223(97)00555-6 · DOI
  23. Bhugra, 2005, The global prevalence of schizophrenia, PLoS Med., 2, 372, 10.1371/journal.pmed.0020151 · DOI · Paper page
  24. Bianchi, 2007, Treatment monitoring of brain creatine deficiency syndromes: a 1H- and 31P-MR spectroscopy study, AJNR Am. J. Neuroradiol., 28, 548
  25. Bianchi, 2000, Reversible brain creatine deficiency in two sisters with normal blood creatine level, Ann. Neurol., 47, 511, 10.1002/1531-8249(200004)47:4<511::AID-ANA15>3.0.CO;2-N · DOI
  26. Bizzi, 2002, X-linked creatine deficiency syndrome: a novel mutation in creatine transporter gene SLC6A8, Ann. Neurol., 52, 227, 10.1002/ana.10246 · DOI
  27. Bjelland, 2003, Folate, vitamin B12, homocysteine, and the MTHFR 677C->T polymorphism in anxiety and depression: the Hordaland Homocysteine Study, Arch. Gen. Psychiatry, 60, 618, 10.1001/archpsyc.60.6.618 · DOI · Paper page
  28. Bluml, 1999, Quantitative proton-decoupled 31P MRS of the schizophrenic brain in vivo, J. Comput. Assist. Tomogr., 23, 272, 10.1097/00004728-199903000-00017 · DOI
  29. Bodnar, 2005, Nutrition and depression: implications for improving mental health among childbearing-aged women, Biol. Psychiatry, 58, 679, 10.1016/j.biopsych.2005.05.009 · DOI · Paper page
  30. Braissant, 2008, AGAT, GAMT and SLC6A8 distribution in the central nervous system, in relation to creatine deficiency syndromes: a review, J. Inherit. Metab. Dis., 10.1007/s10545-008-0826-9 · DOI
  31. Braissant, 2005, Creatine synthesis and transport during rat embryogenesis: spatiotemporal expression of AGAT, GAMT and CT1, BMC Dev. Biol., 5, 9, 10.1186/1471-213X-5-9 · DOI
  32. Brambilla, 2005, H Magnetic resonance spectroscopy study of dorsolateral prefrontal cortex in unipolar mood disorder patients, Psychiatry Res.: Neuroimaging, 138, 131, 10.1016/j.pscychresns.2004.12.001 · DOI
  33. Brdiczka, 1998, The molecular structure of mitochondrial contact sites. Their role in regulation of energy metabolism and permeability transition, Biofactors, 8, 235, 10.1002/biof.5520080311 · DOI
  34. Brosnan, 2007, New insights into creatine function and synthesis, Adv. Enzyme Regul., 47, 252, 10.1016/j.advenzreg.2006.12.005 · DOI
  35. Brustovetsky, 2001, On the mechanisms of neuroprotection by creatine and phosphocreatine, J. Neurochem., 76, 425, 10.1046/j.1471-4159.2001.00052.x · DOI
  36. Búrigo, 2006, Decreased creatine kinase activity caused by electroconvulsive shock, Neurochem. Res., 31, 877, 10.1007/s11064-006-9091-1 · DOI
  37. Bürklen, 2006, The creatine kinase/creatine connection to alzheimer's disease: CK Inactivation, APP-CK complexes and focal creatine deposits, J. Biomed. Biotechnol., 2006, 1
  38. Caetano, 2005, Proton spectroscopy study of the left dorsolateral prefrontal cortex in pediatric depressed patients, Neurosci. Lett., 384, 321, 10.1016/j.neulet.2005.04.099 · DOI
  39. Caetano, 2011, Lower N-acetyl-aspartate levels in prefrontal cortices in pediatric bipolar disorder: a (1)H magnetic resonance spectroscopy study, J. Am. Acad. Child Adolesc. Psychiatry, 50, 85, 10.1016/j.jaac.2010.10.007 · DOI
  40. Calabrese, 1992, 31phosphorus magnetic resonance spectroscopy of the temporal lobes in schizophrenia, Biol. Psychiatry, 32, 26, 10.1016/0006-3223(92)90139-Q · DOI
  41. Cecil, 2003, Proton magnetic resonance spectroscopy of the frontal lobe and cerebellar vermis in children with a mood disorder and a familial risk for bipolar disorders, J. Child Adolesc. Psychopharmacol., 13, 545, 10.1089/104454603322724931 · DOI
  42. Christensen, 2001, The effect of food intake on mood, Clin. Nutr., 20, 161, 10.1054/clnu.2001.0420 · DOI
  43. Chung, 2009, Creatine kinase level may not be associated with motor activity but with simple mood state in Korean unmedicated bipolar patients, Eur. Neuropsychopharmacol., 19, S465, 10.1016/S0924-977X(09)70729-1 · DOI
  44. Coffey, 1970, Serum creatine kinase, aldolase, and copper in acute and chronic schizophrenics, Biol. Psychiatry, 2, 331
  45. Coplan, 2006, Decreased choline and creatine concentrations in centrum semiovale in patients with generalized anxiety disorder: relationship to IQ and early trauma, Psychiatry Res. Neuroimaging, 147, 27, 10.1016/j.pscychresns.2005.12.011 · DOI · Paper page
  46. Czéh, 2001, Stress-induced changes in cerebral metabolites, hippocampal volume, and cell proliferation are prevented by antidepressant treatment with tianeptine, Proc. Natl. Acad. Sci. U.S.A., 98, 12796, 10.1073/pnas.211427898 · DOI · Paper page
  47. Dager, 2004, Brain metabolic alterations in medication-free patients with bipolar disorder, Arch. Gen. Psychiatry, 61, 450, 10.1001/archpsyc.61.5.450 · DOI · Paper page
  48. Dalbo, 2008, Putting to rest the myth of creatine supplementation leading to muscle cramps and dehydration, Br. J. Sports Med., 42, 567
  49. Danivas, 2010, Electroconvulsive therapy in the treatment of delirious mania: a report of 2 patients, J. ECT, 26, 278, 10.1097/YCT.0b013e3181da848f · DOI
  50. Deicken, 1994, 31phosphorus magnetic resonance spectroscopy of the frontal and parietal lobes in chronic schizophrenia, Biol. Psychiatry, 36, 503, 10.1016/0006-3223(94)90613-0 · DOI
  51. Deicken, 1995, Asymmetry of temporal lobe phosphorous metabolism in schizophrenia: a 31phosphorous magnetic resonance spectroscopic imaging study, Biol. Psychiatry, 38, 279, 10.1016/0006-3223(94)00372-A · DOI
  52. Deminice, 2008, Effects of creatine supplementation on homocysteine levels and lipid peroxidation in rats, Br. J. Nutr., 102, 110, 10.1017/S0007114508162985 · DOI
  53. Dincheva, 2012, Impact of the BDNF Val66Met polymorphism on cognition: implications for behavioral genetics, Neuroscientist, 10.1177/1073858411431646 · DOI
  54. Dolder, 2003, Inhibition of the mitochondrial permeability transition by creatine kinase substrates. Requirement for microcompartmentation, J. Biol. Chem., 278, 17760, 10.1074/jbc.M208705200 · DOI · Paper page
  55. Ducray, 2007, Creatine promotes the GABAergic phenotype in human fetal spinal cord cultures, Brain Res., 1137, 50, 10.1016/j.brainres.2006.12.038 · DOI
  56. Ducray, 2007, Creatine treatment promotes differentiation of GABA-ergic neuronal precursors in cultured fetal rat spinal cord, J. Neurosci. Res., 85, 1863, 10.1002/jnr.21337 · DOI
  57. Duman, 2006, A neurotrophic model for stress-related mood disorders, Biol. Psychiatry, 59, 1116, 10.1016/j.biopsych.2006.02.013 · DOI · Paper page
  58. Ende, 2003, Multiregional 1 H-MRSI of the hippocampus, thalamus, and basal ganglia in schizophrenia, Eur. Arch. Psychiatry Clin. Neurosci., 253, 9, 10.1007/s00406-003-0398-5 · DOI
  59. Ende, 2007, Subcortical and medial temporal MR-detectable metabolite abnormalities in unipolar major depression, Eur. Arch. Psychiatry Clin. Neurosci., 257, 36, 10.1007/s00406-006-0680-4 · DOI
  60. Erakovic, 2001, Altered activities of rat brain metabolic enzymes in electroconvulsive shock-induced seizures, Epilepsia, 42, 181, 10.1046/j.1528-1157.2001.30499.x · DOI
  61. Farchione, 2002, Proton magnetic resonance spectroscopic imaging in pediatric major depression, Biol. Psychiatry, 52, 86, 10.1016/S0006-3223(02)01340-9 · DOI
  62. Faulstich, 1984, Creatine phosphokinase, the MMPI, and psychosis, Am. J. Psychiatry, 141, 584, 10.1176/ajp.141.4.584 · DOI
  63. Feier, 2011, Creatine kinase levels in patients with bipolar disorder: depressive, manic, and euthymic phases, Rev. Bras. Psiquiatr., 33, 171, 10.1590/S1516-44462011005000005 · DOI
  64. Forlenza, 2010, Effect of brain-derived neurotrophic factor Val66Met polymorphism and serum levels on the progression of mild cognitive impairment, World J. Biol. Psychiatry, 11, 774, 10.3109/15622971003797241 · DOI
  65. Frey, 2005, A proton magnetic resonance spectroscopy investigation of the dorsolateral prefrontal cortex in acute mania, Hum. Psychopharm. Clin., 20, 133, 10.1002/hup.671 · DOI
  66. Frey, 2007, Abnormal cellular energy and phospholipid metabolism in the left dorsolateral prefrontal cortex of medication-free individuals with bipolar disorder: an in vivo 1H MRS study, Bipolar Disord., 9, 119, 10.1111/j.1399-5618.2007.00454.x · DOI
  67. Frey, 2007, Brain-derived neurotrophic factor val66met polymorphism affects prefrontal energy metabolism in bipolar disorder, Neuroreport, 18, 1567, 10.1097/WNR.0b013e3282ef7082 · DOI
  68. Frye, 2007, Increased anterior cingulate/medial prefrontal cortical glutamate and creatine in bipolar depression, Neuropsychopharmacology, 32, 2490, 10.1038/sj.npp.1301387 · DOI
  69. Fuchs, 2002, Synaptic plasticity and tianeptine: structural regulation, Eur. Psychiatry, 17, 311, 10.1016/S0924-9338(02)00652-1 · DOI
  70. Fujimoto, 1992, Study of chronic schizophrenics using 31P magnetic resonance chemical shift imaging, Acta Psychiatr. Scand., 86, 455, 10.1111/j.1600-0447.1992.tb03297.x · DOI
  71. Fujimoto, 1996, Proton magnetic resonance spectroscopy of basal ganglia in chronic schizophrenia, Biol. Psychiatry, 40, 14, 10.1016/0006-3223(95)00316-9 · DOI
  72. Fukuzako, 1999, Changes in levels of phosphorus metabolites in temporal lobes of drug-naive schizophrenic patients, Am. J. Psychiatry, 156, 1205, 10.1176/ajp.156.8.1205 · DOI
  73. Fukuzako, 1995, Proton magnetic resonance spectroscopy of the left medial temporal and frontal lobes in chronic schizophrenia: preliminary report, Psychiatry Res., 61, 193, 10.1016/0925-4927(95)02622-5 · DOI
  74. Gabbay, 2007, Lateralized caudate metabolic abnormalities in adolescent major depressive disorder: a proton MR spectroscopy study, Am. J. Psychiatry, 164, 1881, 10.1176/appi.ajp.2007.06122032 · DOI
  75. Gallinat, 2010, Met carriers of BDNF Val66Met genotype show increased N-acetylaspartate concentration in the anterior cingulate cortex, Neuroimage, 49, 767, 10.1016/j.neuroimage.2009.08.018 · DOI
  76. Gledhill, 1988, Race-gender differences in serum creatine kinase activity: a study among South Africans, J. Neurol. Neurosurg. Psychiatry, 51, 301, 10.1136/jnnp.51.2.301 · DOI
  77. Gong, 2011, Chronic mild stress damages mitochondrial ultrastructure and function in mouse brain, Neurosci. Lett., 488, 76, 10.1016/j.neulet.2010.11.006 · DOI
  78. Gosling, 1972, Creatine phosphokinase activity in newly admitted psychiatric patients, Br. J. Psychiatry, 121, 351, 10.1192/bjp.121.4.351 · DOI
  79. Groeneveld, 2003, A randomized sequential trial of creatine in amyotrophic lateral sclerosis, Ann. Neurol., 53, 437, 10.1002/ana.10554 · DOI · Paper page
  80. Gruber, 2003, Quantification of Metabolic Differences in the Frontal Brain of Depressive Patients and Controls Obtained by 1H-MRS at 3 Tesla, Invest. Radiol., 38, 403, 10.1097/01.rli.0000073446.43445.20 · DOI
  81. Gualano, 2010, Exploring the therapeutic role of creatine supplementation, Amino Acids, 38, 31, 10.1007/s00726-009-0263-6 · DOI · Paper page
  82. Hamakawa, 1998, Quantitative proton magnetic resonance spectroscopy of the basal ganglia in patients with affective disorders, Eur. Arch. Psychiatry Clin. Neurosci., 248, 53, 10.1007/s004060050017 · DOI
  83. Hamakawa, 1999, Quantitative proton magnetic resonance spectroscopy of the bilateral frontal lobes in patients with bipolar disorder, Psychol. Med., 29, 639, 10.1017/S0033291799008442 · DOI
  84. Hasin, 2005, Epidemiology of major depressive disorder: Results from the National Epidemiologic Survey on Alcoholism and Related Conditions, Arch. Gen. Psychiatry, 62, 1097, 10.1001/archpsyc.62.10.1097 · DOI · Paper page
  85. Hasler, 2005, Normal Prefrontal Gamma-Aminobutyric Acid Levels in Remitted Depressed Subjects Determined by Proton Magnetic Resonance Spectroscopy, Biol. Psychiatry, 58, 969, 10.1016/j.biopsych.2005.05.017 · DOI
  86. Hermesh, 2002, Serum creatine kinase levels in untreated hospitalized adolescents during acute psychosis, J. Am. Acad. Child Adolesc. Psychiatry, 41, 1045, 10.1097/00004583-200209000-00004 · DOI
  87. Ikeda, 1977, Serum creatine phosphokinase activity in newly admitted chronic alcoholics, Folia Psychiatr. Neurol. Jpn., 31, 9
  88. in ‘t Zandt, 2004, Cerebral creatine kinase deficiency influences metabolite levels and morphology in the mouse brain: a quantitative in vivo 1H and 31P magnetic resonance study, J. Neurochem., 90, 1321, 10.1111/j.1471-4159.2004.02599.x · DOI
  89. Iosifescu, 2008, Brain bioenergetics and response to triiodothyronine augmentation in major depressive disorder, Biol. Psychiatry, 63, 1127, 10.1016/j.biopsych.2007.11.020 · DOI · Paper page
  90. Jacka, 2010, Association of Western and traditional diets with depression and anxiety in women, Am. J. Psychiatry, 167, 305, 10.1176/appi.ajp.2009.09060881 · DOI · Paper page
  91. Jacka, 2011, Diet quality in bipolar disorder in a population-based sample of women, J. Affect. Disord., 129, 332, 10.1016/j.jad.2010.09.004 · DOI
  92. Jayakumar, 2010, High energy phosphate abnormalities normalize after antipsychotic treatment in schizophrenia: a longitudinal 31P MRS study of basal ganglia, Psychiatry Res.: Neuroimaging, 181, 237, 10.1016/j.pscychresns.2009.10.010 · DOI
  93. Jensen, 2004, Focal changes in brain energy and phospholipid metabolism in first-episode schizophrenia: 31P-MRS chemical shift imaging study at 4 Tesla, Br. J. Psychiatry, 184, 409, 10.1192/bjp.184.5.409 · DOI
  94. Jost, 2002, Creatine kinase B-driven energy transfer in the brain is important for habituation and spatial learning behaviour, mossy fibre field size and determination of seizure susceptibility, Eur. J. Neurosci., 15, 1692, 10.1046/j.1460-9568.2002.02001.x · DOI
  95. Juhn, 1999, Oral creatine supplementation in male collegiate athletes: a survey of dosing habits and side effects, J. Am. Diet. Assoc., 99, 593, 10.1016/S0002-8223(99)00145-5 · DOI
  96. Kaptsan, 2007, Lack of efficacy of 5 grams daily of creatine in schizophrenia: a randomized, double-blind, placebo-controlled trial, J. Clin. Psychiatry, 68, 881, 10.4088/JCP.v68n0609 · DOI
  97. Kato, 2008, Molecular neurobiology of bipolar disorder: a disease of ‘mood-stabilizing neurons’?, Trends Neurosci., 31, 495, 10.1016/j.tins.2008.07.007 · DOI
  98. Kato, 1995, Lateralized abnormality of high-energy phosphate and bilateral reduction of phosphomonoester measured by phosphorus-31 magnetic resonance spectroscopy of the frontal lobes in schizophrenia, Psychiatry Res., 61, 151, 10.1016/0925-4927(95)02752-J · DOI
  99. Kato, 1992, Brain phosphorous metabolism in depressive disorders detected by phosphorus-31 magnetic resonance spectroscopy, J. Affect. Disord., 26, 223, 10.1016/0165-0327(92)90099-R · DOI · Paper page
  100. Kato, 1994, Reduction of brain phosphocreatine in bipolar II disorder detected by phosphorus-31 magnetic resonance spectroscopy, J. Affect. Disord., 31, 125, 10.1016/0165-0327(94)90116-3 · DOI · Paper page
  101. Kendall, 2005, Creatine supplementation for weak muscles in persons with chronic tetraplegia: a randomized double-blind placebo-controlled crossover trial, J. Spinal Cord Med., 28, 208, 10.1080/10790268.2005.11753814 · DOI
  102. Kennedy, 2006, A review of antidepressant treatments today, Eur. Neuropsychopharmacol., 16, S619, 10.1016/S0924-977X(06)70007-4 · DOI
  103. Keshavan, 2009, Striatal metabolic alterations in non-psychotic adolescent offspring at risk for schizophrenia: a 1H spectroscopy study, Schizophr. Res., 115, 88, 10.1016/j.schres.2009.08.012 · DOI
  104. Kessler, 1994, Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey, Arch. Gen. Psychiatry, 51, 8, 10.1001/archpsyc.1994.03950010008002 · DOI · Paper page
  105. Kim, 2010, Desipramine attenuates forced swim test-induced behavioral and neurochemical alterations in mice: an in vivo 1H-MRS study at 9.4T, Brain Res., 1348, 105, 10.1016/j.brainres.2010.05.097 · DOI
  106. Knox, 2010, Single prolonged stress decreases glutamate, glutamine, and creatine concentrations in the rat medial prefrontal cortex, Neurosci. Lett., 480, 16, 10.1016/j.neulet.2010.05.052 · DOI
  107. Koga, 2005, Brain creatine functions to attenuate acute stress responses through GABAnergic system in chicks, Neuroscience, 132, 65, 10.1016/j.neuroscience.2005.01.004 · DOI
  108. Kondo, 2011, Review: magnetic resonance spectroscopy studies of pediatric major depressive disorder, Depress. Res. Treat., 2011, 1, 10.1155/2011/650450 · DOI
  109. Kondo, 2011, Open-label adjunctive creatine for female adolescents with SSRI-resistant major depressive disorder: a 31-phosphorus magnetic resonance spectroscopy study, J. Affect. Disord., 135, 354, 10.1016/j.jad.2011.07.010 · DOI · Paper page
  110. Kornstein, 2000, Gender differences in chronic major and double depression, J. Affect. Disord., 60, 1, 10.1016/S0165-0327(99)00158-5 · DOI · Paper page
  111. Korzun, 2004, Oral creatine supplements lower plasma homocysteine concentrations in humans, Clin. Lab. Sci., 17, 102
  112. Koshy, 1999, Interstitial nephritis in a patient taking creatine, N. Engl. J. Med., 340, 814, 10.1056/NEJM199903113401017 · DOI
  113. Kuczmarski, 2010, Higher Healthy Eating Index-2005 scores associated with reduced symptoms of depression in an urban population: findings from the Healthy Aging in Neighborhoods of Diversity Across the Life Span (HANDLS) study, J. Am. Diet. Assoc., 110, 383, 10.1016/j.jada.2009.11.025 · DOI
  114. Kumar, 2002, Frontal white matter biochemical abnormalities in late-life major depression detected with proton magnetic resonance spectroscopy, Am. J. Psychiatry, 159, 630, 10.1176/appi.ajp.159.4.630 · DOI
  115. Kuehl, 2000, Re: long-term oral creatine supplementation does not impair renal function in healthy athletes, Med. Sci. Sports Exerc., 32, 248, 10.1097/00005768-200001000-00037 · DOI
  116. Li, 2009, Cross-sectional assessment of diet quality in individuals with a lifetime history of attempted suicide, Psychiatry Res., 165, 111, 10.1016/j.psychres.2007.09.004 · DOI
  117. Lieberman, 2003, Nutrition, brain function and cognitive performance, Appetite, 40, 245, 10.1016/S0195-6663(03)00010-2 · DOI
  118. Lobley, 1996, The importance of transmethylation reactions to methionine metabolism in sheep: effects of supplementation with creatine and choline, Br. J. Nutr., 75, 47, 10.1079/BJN19960109 · DOI
  119. Lugenbiel, 2010, Creatine transporter expression after antidepressant therapy in rats bred for learned helplessness, World J. Biol. Psychiatry, 11, 329, 10.3109/15622970903131597 · DOI
  120. Lutkenhoff, 2010, Proton MRS in twin pairs discordant for schizophrenia, Mol. Psychiatry, 15, 308, 10.1038/mp.2008.87 · DOI
  121. Lyoo, 2003, Multinuclear magnetic resonance spectroscopy of high-energy phosphate metabolites in human brain following oral supplementation of creatine-monohydrate, Psychiatry Res., 123, 87, 10.1016/S0925-4927(03)00046-5 · DOI · Paper page
  122. MacDonald, 2006, Decrease in creatine kinase messenger RNA expression in the hippocampus and dorsolateral prefrontal cortex in bipolar disorder, Bipolar Disord., 8, 255, 10.1111/j.1399-5618.2006.00302.x · DOI
  123. Maddock, 2012, MR Spectroscopic Studies of the Brain in Psychiatric Disorders, Curr. Top. Behav. Neurosci.
  124. Mak, 2009, Immunohistochemical localisation of the creatine transporter in the rat brain, Neuroscience, 163, 571, 10.1016/j.neuroscience.2009.06.065 · DOI
  125. Malhi, 2002, Magnetic resonance spectroscopy and its applications in psychiatry, Aust. N. Z. J. Psychiatry, 36, 31, 10.1046/j.1440-1614.2002.00992.x · DOI
  126. Manor, 1999, Elevated serum levels of creatine kinase in acute psychotic patients, Harefuah, 136, 639
  127. Marcus, 2005, Gender differences in depression: findings from the STAR*D study, J. Affect. Disord., 87, 141, 10.1016/j.jad.2004.09.008 · DOI · Paper page
  128. Martin, 2009, The neurobiology of anxiety disorders: brain imaging, genetics, and psychoneuroendocrinology, Psychiatr. Clin. North Am., 32, 549, 10.1016/j.psc.2009.05.004 · DOI · Paper page
  129. Martin, 1972, Cerebrospinal fluid creatine kinase in acutely psychotic patients, J. Neurol. Neurosurg. Psychiatry, 35, 726, 10.1136/jnnp.35.5.726 · DOI
  130. Masand, 2003, Tolerability and adherence issues in antidepressant therapy, Clin. Ther., 25, 2289, 10.1016/S0149-2918(03)80220-5 · DOI
  131. Massana, 2002, Reduced levels of creatine in the right medial temporal lobe region of panic disorder patients detected with 1H magnetic resonance spectroscopy, Neuroimage, 16, 836, 10.1006/nimg.2002.1083 · DOI
  132. Matthews, 1999, Creatine and cyclocreatine attenuate MPTP neurotoxicity, Exp. Neurol., 157, 142, 10.1006/exnr.1999.7049 · DOI · Paper page
  133. Matthews, 1998, Neuroprotective effects of creatine and cyclocreatine in animal models of Huntington's disease, J. Neurosci., 18, 156, 10.1523/JNEUROSCI.18-01-00156.1998 · DOI · Paper page
  134. McCall, 2007, Pharmacokinetics of creatine, Subcell. Biochem., 46, 261
  135. McGowan, 2008, Diet and the epigenetic (re)programming of phenotypic differences in behavior, Brain Res., 1237, 12, 10.1016/j.brainres.2008.07.074 · DOI
  136. McGrath, 2008, Schizophrenia: a concise overview of incidence, prevalence, and mortality, Epidemiol. Rev., 30, 67, 10.1093/epirev/mxn001 · DOI · Paper page
  137. McMorris, 2007, Creatine supplementation and cognitive performance in elderly individuals, Neuropsychol. Dev. Cogn. B Aging Neuropsychol. Cogn., 14, 517, 10.1080/13825580600788100 · DOI · Paper page
  138. Melkersson, 2006, Serum creatine kinase levels in chronic psychosis patients – a comparison between atypical and conventional antipsychotics, Prog. Neuropsychopharmacol. Biol. Psychiatry, 30, 1277, 10.1016/j.pnpbp.2006.04.025 · DOI
  139. Meltzer, 1968, Creatine kinase and aldolase in serum: abnormality common to acute psychoses, Science, 159, 1368, 10.1126/science.159.3821.1368 · DOI
  140. Meltzer, 1970, Increased activity of creatine phosphokinase and aldolase activity in the acute psychoses: case reports, J. Psychiatr. Res., 7, 249, 10.1016/0022-3956(70)90019-1 · DOI
  141. Meltzer, 1969, Serum-enzyme changes in newly admitted psychiatric patients, I. Arch. Gen. Psychiatry, 21, 731, 10.1001/archpsyc.1969.01740240091011 · DOI
  142. Meltzer, 1973, Creatine phosphokinase activity and clinical symptomatology. A study in acute schizophrenic patients, Arch. Gen. Psychiatry, 29, 589, 10.1001/archpsyc.1973.04200050005001 · DOI
  143. Meltzer, 1976, Serum creatine phosphokinase in schizophrenia, Am. J. Psychiatry, 133, 192, 10.1176/ajp.133.2.192 · DOI
  144. Meltzer, 1996, Marked elevations of serum creatine kinase activity associated with antipsychotic drug treatment, Neuropsychopharmacology, 15, 395, 10.1016/0893-133X(95)00276-J · DOI
  145. Mercimek-Mahmutoglu, 2006, GAMT deficiency: features, treatment, and outcome in an inborn error of creatine synthesis, Neurology, 67, 480, 10.1212/01.wnl.0000234852.43688.bf · DOI
  146. Merkl, 2011, Abnormal cingulate and prefrontal cortical neurochemistry in major depression after electroconvulsive therapy, Biol. Psychiatry, 69, 772, 10.1016/j.biopsych.2010.08.009 · DOI
  147. Michael, 2003, Metabolic changes within the left dorsolateral prefrontal cortex occurring with electroconvulsive therapy in patients with treatment resistant unipolar depression, Psychol. Med., 33, 1277, 10.1017/S0033291703007931 · DOI · Paper page
  148. Michaelis, 1999, Proton MRS of oral creatine supplementation in rats. Cerebral metabolite concentrations and ischemic challenge, NMR Biomed., 12, 309, 10.1002/(SICI)1099-1492(199908)12:5<309::AID-NBM572>3.0.CO;2-Y · DOI
  149. Mirza, 2006, Increased medial thalamic creatine–phosphocreatine found by proton magnetic resonance spectroscopy in children with obsessive–compulsive disorder versus major depression and healthy controls, J. Child Neurol., 21, 106, 10.1177/08830738060210020201 · DOI
  150. Moore, 1997, Lower levels of nucleoside triphosphate in the basal ganglia of depressed subjects: a phosphorous-31 magnetic resonance spectroscopy study, Am. J. Psychiatry, 154, 116, 10.1176/ajp.154.1.116 · DOI
  151. Mudd, 1975, Labile methyl balances for normal humans on various dietary regimens, Metabolism, 24, 721, 10.1016/0026-0495(75)90040-2 · DOI · Paper page
  152. Muntjewerff, 2006, Homocysteine, methylenetetrahydrofolate reductase and risk of schizophrenia: a meta-analysis, Mol. Psychiatry, 11, 143, 10.1038/sj.mp.4001746 · DOI
  153. Murashita, 2000, Altered brain energy metabolism in lithium-resistant bipolar disorder detected by photic stimulated 31P-MR spectroscopy, Psychol. Med., 30, 107, 10.1017/S0033291799001439 · DOI
  154. Nahin, 2009, Costs of complementary and alternative medicine (CAM) and frequency of visits to CAM practitioners: United States, 2007, Natl. Health Stat. Report, 1
  155. Nash, 1994, Cloning, pharmacological characterization, and genomic localization of the human creatine transporter, Receptors Channels, 2, 165
  156. Nery, 2009, Normal metabolite levels in the left dorsolateral prefrontal cortex of unmedicated major depressive disorder patients: a single voxel 1H spectroscopy study, Psychiatry Res.: Neuroimaging, 174, 177, 10.1016/j.pscychresns.2009.05.003 · DOI
  157. Niklasson, 1984, Brain energy metabolism and blood–brain barrier permeability in depressive patients: analyses of creatine, creatinine, urate, and albumin in CSF and blood, Biol. Psychiatry, 19, 1183
  158. Nolen-Hoeksema, 1993, Response styles and the duration of episodes of depressed mood, J. Abnorm. Psychol., 102, 20, 10.1037/0021-843X.102.1.20 · DOI · Paper page
  159. O’Donnell, 2000, Chronic lithium and sodium valproate both decrease the concentration of myo-inositol and increase the concentration of inositol monophosphates in rat brain, Brain Res., 880, 84, 10.1016/S0006-8993(00)02797-9 · DOI
  160. O’Neill, 2004, H MRSI evidence of metabolic abnormalities in childhood-onset schizophrenia, Neuroimage, 21, 1781, 10.1016/j.neuroimage.2003.11.005 · DOI
  161. Ohrmann, 2007, Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study, J. Psychiatr. Res., 41, 625, 10.1016/j.jpsychires.2006.07.002 · DOI · Paper page
  162. Ohtsuki, 2002, The blood–brain barrier creatine transporter is a major pathway for supplying creatine to the brain, J. Cereb. Blood Flow Metab., 22, 1327, 10.1097/01.WCB.0000033966.83623.7D · DOI
  163. Oliveira, 2008, The involvement of the polyamines binding sites at the NMDA receptor in creatine-induced spatial learning enhancement, Behav. Brain Res., 187, 200, 10.1016/j.bbr.2007.09.004 · DOI
  164. Öngür, 2010, T2 relaxation time abnormalities in bipolar disorder and schizophrenia, Magn. Reson. Med., 63, 1, 10.1002/mrm.22148 · DOI
  165. Öngür, 2009, Creatine abnormalities in schizophrenia and bipolar disorder, Psychiatry Res.: Neuroimaging, 172, 44, 10.1016/j.pscychresns.2008.06.002 · DOI
  166. Osher, 2004, Elevated homocysteine levels in euthymic bipolar disorder patients showing functional deterioration, Bipolar Disord., 6, 82, 10.1046/j.1399-5618.2003.00082.x · DOI
  167. Pan, 2007, Cerebral energetic effects of creatine supplementation in humans, Am. J. Physiol. Regul. Integr. Comp. Physiol., 292, R1745, 10.1152/ajpregu.00717.2006 · DOI · Paper page
  168. Patel, 2008, Neurochemical alterations in adolescent bipolar depression: a proton magnetic resonance spectroscopy pilot study of the prefrontal cortex, J. Child Adolesc. Psychopharmacol., 18, 623, 10.1089/cap.2007.151 · DOI
  169. Perasso, 2003, Kinetics of creatine in blood and brain after intraperitoneal injection in the rat, Brain Res., 974, 37, 10.1016/S0006-8993(03)02547-2 · DOI
  170. Persky, 2003, Single- and multiple-dose pharmacokinetics of oral creatine, J. Clin. Pharmacol., 43, 29, 10.1177/0091270002239703 · DOI
  171. Pfleiderer, 2003, Effective electroconvulsive therapy reverses glutamate/glutamine deficit in the left anterior cingulum of unipolar depressed patients, Psychiatry Res.: Neuroimaging, 122, 185, 10.1016/S0925-4927(03)00003-9 · DOI · Paper page
  172. Pettegrew, 1991, Alterations in brain high-energy phosphate and membrane phospholipid metabolism in first-episode, drug-naive schizophrenics, Arch. Gen. Psychiatry, 48, 563, 10.1001/archpsyc.1991.01810300075011 · DOI · Paper page
  173. Poortmans, 1999, Long-term oral creatine supplementation does not impair renal function in healthy athletes, Med. Sci. Sports Exerc., 31, 1108, 10.1097/00005768-199908000-00005 · DOI · Paper page
  174. Ramirez, 2002, Sexual dimorphism in rat cerebrum and cerebellum: different patterns of catalytically active creatine kinase isoenzymes during postnatal development and aging, Int. J. Dev. Neurosci., 20, 627, 10.1016/S0736-5748(02)00102-8 · DOI
  175. Réus, 2012, Administration of harmine and imipramine alters creatine kinase and mitochondrial respiratory chain activities in the rat brain, Depress. Res. Treat., 2012, 1, 10.1155/2012/987397 · DOI
  176. Réus, 2011, Administration of memantine and imipramine alters mitochondrial respiratory chain and creatine kinase activities in rat brain, J. Neural Transm.
  177. Riehemann, 1999, Frontal lobe in vivo (31)P-MRS reveals gender differences in healthy controls, not in schizophrenics, NMR Biomed., 12, 483, 10.1002/(SICI)1099-1492(199912)12:8<483::AID-NBM589>3.0.CO;2-D · DOI
  178. Rosenberg, 2000, Brain chemistry in pediatric depression, Biol. Psychiatry, 47, 95S, 10.1016/S0006-3223(00)00578-3 · DOI
  179. Roy, 2002, Dietary supplementation with creatine monohydrate prevents corticosteroid-induced attenuation of growth in young rats, Can. J. Physiol. Pharmacol., 80, 1008, 10.1139/y02-129 · DOI · Paper page
  180. Royes, 2008, Neuromodulatory effect of creatine on extracellular action potentials in rat hippocampus: role of NMDA receptors, Neurochem. Int., 53, 33, 10.1016/j.neuint.2008.04.008 · DOI
  181. Ryu, 2005, The therapeutic role of creatine in Huntington's disease, Pharmacol. Ther., 108, 193, 10.1016/j.pharmthera.2005.04.008 · DOI
  182. Salomons, 2001, X-linked creatine-transporter gene (SLC6A8) defect: a new creatine-deficiency syndrome, Am. J. Hum. Genet., 68, 1497, 10.1086/320595 · DOI · Paper page
  183. Sanacora, 2004, Subtype-specific alterations of γ-aminobutyric acid and glutamate in patients with major depression, Arch. Gen. Psychiatry, 61, 705, 10.1001/archpsyc.61.7.705 · DOI · Paper page
  184. Sanches, 2010, Emerging drugs for bipolar disorder, Expert. Opin. Emerg. Drugs, 15, 453, 10.1517/14728214.2010.492393 · DOI
  185. Sanchez-Villegas, 2009, Association between folate, vitamin B(6) and vitamin B(12) intake and depression in the SUN cohort study, J. Hum. Nutr. Diet., 22, 122, 10.1111/j.1365-277X.2008.00931.x · DOI
  186. Santos, 2009, Brain creatine kinase activity is increased by chronic administration of paroxetine, Brain Res. Bull., 80, 327, 10.1016/j.brainresbull.2009.09.007 · DOI
  187. Sapolsky, 2000, Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders, Arch. Gen. Psychiatry, 57, 925, 10.1001/archpsyc.57.10.925 · DOI · Paper page
  188. Sartorius, 2003, Specific creatine rise in learned helplessness induced by electroconvulsive shock treatment, Neuroreport, 14, 2199, 10.1097/00001756-200312020-00013 · DOI
  189. Sassi, 2005, Reduced NAA levels in the dorsolateral prefrontal cortex of young bipolar patients, Am. J. Psychiatry, 162, 2109, 10.1176/appi.ajp.162.11.2109 · DOI
  190. Sautter, 1995, A preliminary study of the neuropsychological heterogeneity of familial schizophrenia, Schizophr. Res., 18, 1, 10.1016/0920-9964(95)00015-1 · DOI
  191. Schulze, 2003, Lack of creatine in muscle and brain in an adult with GAMT deficiency, Ann. Neurol., 53, 248, 10.1002/ana.10455 · DOI
  192. Schuff, 2008, Abnormal N-acetylaspartate in hippocampus and anterior cingulate in posttraumatic stress disorder, Psychiatry Res.: Neuroimaging, 162, 147, 10.1016/j.pscychresns.2007.04.011 · DOI
  193. Schweid, 1972, Creatine phosphokinase and psychosis, Arch. Gen. Psychiatry, 26, 263, 10.1001/archpsyc.1972.01750210071013 · DOI
  194. Segal, 2007, Serum creatine kinase level in unmedicated nonpsychotic, psychotic, bipolar and schizoaffective depressed patients, Eur. Neuropsychopharmacol., 17, 194, 10.1016/j.euroneuro.2006.08.010 · DOI
  195. Seifried, 2007, Oxidative stress and antioxidants: a link to disease and prevention?, J. Nutr. Biochem., 18, 168, 10.1016/j.jnutbio.2006.12.003 · DOI
  196. Sestili, 2011, Creatine as an antioxidant, Amino Acids, 40, 1385, 10.1007/s00726-011-0875-5 · DOI
  197. Shao, 2006, Risk assessment for creatine monohydrate, Regul. Toxicol. Pharmacol., 45, 242, 10.1016/j.yrtph.2006.05.005 · DOI
  198. Sheth, 2006, Rhabdomyolysis and acute renal failure following arthroscopic knee surgery in a college football player taking creatine supplements, Clin. Nephrol., 65, 134, 10.5414/CNP65134 · DOI
  199. Shioiri, 1996, High-energy phosphate metabolism in the frontal lobes of patients with panic disorder detected by phase-encoded 31P-MRS, Biol. Psychiatry, 40, 785, 10.1016/0006-3223(95)00487-4 · DOI
  200. Sigmundsson, 2003, Frontal lobe N-acetylaspartate correlates with psychopathology in schizophrenia: a proton magnetic resonance spectroscopy study, Schizophr. Res., 64, 63, 10.1016/S0920-9964(02)00533-9 · DOI

200 of 238 shown

Cited by

See all 163

Metadata

Authors
Allen, P. J.
Venue
Neuroscience & Biobehavioral Reviews
Publisher
Elsevier BV
Published
2012-05
Volume
36
Issue
5
Pages
1442-1462
ISSN
0149-7634
DOI
10.1016/j.neubiorev.2012.03.005
Cited by
163
References
35
Language
en
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)
Funders
National Center for Complementary and Alternative Medicine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.